Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
P. R. health sci. j ; P. R. health sci. j;17(4): 345-52, Dec. 1998. tab, graf
Artigo em Inglês | LILACS | ID: lil-234848

RESUMO

The pathogenic mechanisms of immunosuppression leading to susceptibility of Mycobacterium tuberculosis (MT) infection in chronic myelocytic leukemia (CML) are not clear. To address this issue, we measured the proliferative response, variation of T cell subpopulations (CD4+, CD8+, TCR-V delta 2 and TCR-V beta 8 T cells) and the cytokine profile (IL-1 beta, IL-2, IL-4, IL-6, IL-10, TNF-alpha, IFN-gamma) after MT stimulation of peripheral blood mononuclear cells (PBMC) in a patient with concomitant CML and active pulmonary tuberculosis. The results were compared to four patients with active pulmonary tuberculosis and no other coexistent diseases. The immunologic response to phytohemagglutinin (PHA) was also evaluated. In contrast to controls, the CML PBMC failed to proliferate in response to MT antigens. Mycobacterium-reactive CD4+, V delta 2 and V beta 8 T cells did not expand after MT stimulation of the CML PBMC. In MT antigens-stimulated cultures from the CML patient, IL-2 was not produced and mild reduction of IL-1 beta and INF-gamma were observed. In contrast, IL-10 was markedly elevated in these cultures. Similarly, PHA-stimulated PBMC from the CML patient showed no expansion of CD4+ and CD8+. T cells. In these cell cultures, INF-gamma concentration in supernatants was decreased and IL-10 was significantly elevated. This study suggests that patients with CML may present a profound immunosuppression of essential cellular and molecular immune effectors, a scenario which might contribute to the development of active tuberculosis. These findings further support the need of establishing immunotherapeutic modalities with potential value for myeloproliferative disorders.


Assuntos
Humanos , Masculino , Adulto , Antígenos de Bactérias/imunologia , Leucemia Mielogênica Crônica BCR-ABL Positiva/imunologia , Mycobacterium tuberculosis/imunologia , Tuberculose Pulmonar/imunologia , Células Cultivadas , Citocinas/imunologia , Tolerância Imunológica , Leucemia Mielogênica Crônica BCR-ABL Positiva/complicações , Contagem de Linfócitos , Subpopulações de Linfócitos/imunologia , Linfócitos T/imunologia , Fatores de Tempo , Tuberculose Pulmonar/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA